Medical News

RSS

Samaritan Medical Center selects ProVation Order Sets electronic solution

Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that Samaritan Medical Center has selected ProVation® Order Sets, powered by UpToDate® Decision Support, as the organization's electronic order set solution.

23 Aug 2011

New report on the immunomodulators market outlook to 2016

TNF inhibitors indicated for the treatment of rheumatoid arthritis, psoriasis and inflammatory bowel disease formed the largest share of the market, according to a new report available on companiesandmarkets.com. The top three products: Remicade, Humira and Enbrel accounted for 40.1% of the market in 2010.

23 Aug 2011

Medicare expands competitive bidding program

The Centers for Medicare and Medicaid Services says this approach, which is geared toward durable medical equipment, will save billions of dollars and could become a model for other efforts to cut costs.

23 Aug 2011

NovaDel, Rechon enter license and distribution agreement for Zolpimist

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced its entry into an exclusive license and distribution agreement with Rechon Life Science AB to manufacture and commercialize Zolpimist® outside the United States and Canada. Zolpimist is our oral spray formulation of zolpidem tartrate approved by the FDA in December of 2008.

23 Aug 2011

Nationwide Children's Hospital marks major milestone toward opening of new campus

Today, Nationwide Children's Hospital marked a major milestone toward the opening of its expanded downtown campus by unveiling concepts for new hospital interiors, outdoor green space as well as a refreshed identity and logo.

23 Aug 2011

New research reveals stubbornly low public awareness of bowel cancer

BRITONS have very low awareness of the signs and symptoms of bowel cancer - the third most common cancer in the UK and second largest cause of cancer deaths each year, new research shows.

23 Aug 2011

GE launches new release of healthcare revenue cycle management solution

GE Healthcare, a leading provider of healthcare information technology, today launched Centricity Business 5.0, the next-generation revenue cycle management solution for hospital networks, academic medical centers, large practices and physician billing groups.

23 Aug 2011

Saint Mark's Cathedral on Capitol Hill to host Seattle AIDS Memorial event

Saint Mark's Cathedral on Capitol Hill will host the Seattle AIDS Memorial on Saturday, September 24, 2011, at 7:00 p.m. Subtitled "30 Years of Sorrow, Comfort and Hope," the memorial commemorates the 30th anniversary of the first HIV/AIDS diagnosis as well as the 25th anniversary of the first AIDS Walk in Seattle.

23 Aug 2011

Scientists identify brain-circuit defect that triggers absence seizures

Researchers at the Stanford University School of Medicine have identified a brain-circuit defect that triggers absence seizures, the most common form of childhood epilepsy.

23 Aug 2011

HTA opens new office in Indianapolis

Healthcare Trust of America, Inc. ("HTA"), a fully integrated, self-administered, self-managed real estate investment trust, is proud to announce that effective August 1, 2011, HTA opened a new office in Indianapolis.

23 Aug 2011

Health Canada grants medical device licence to Gen-Probe's PANTHER system

Gen-Probe Incorporated announced today that Health Canada has granted the Company a medical device license for the PANTHER system, a fully automated and integrated molecular testing system designed with the flexibility to handle a wide range of testing needs.

23 Aug 2011

Children with asthma more likely to have been exposed to tobacco smoking before birth

Children with severe asthma are 3.6 times more likely to have been exposed to tobacco smoking before birth - even without later exposure - than children with a mild form of the disease, according to a multicenter study led by researchers at University of California, San Francisco.

23 Aug 2011

PracticeMax acquires American Billing Services of Portland

PracticeMax, a provider of revenue cycle management and software services, today announced it has acquired American Billing Services (ABS) of Portland, Oregon, expanding the operations and geographical footprint of PracticeMax in the northwestern United States.

23 Aug 2011

Isconova expands Matrix M collaboration with Genocea to treat infectious diseases

Isconova AB, a leading international vaccine adjuvant company and Genocea Biosciences, Inc., a vaccine discovery and development company pioneering a new class of T cell‐based vaccines, today announced the expansion of their collaboration granting Genocea the right to use Isconova's Matrix M in vaccines targeting two additional diseases.

23 Aug 2011

ARUP Laboratories introduces Affymetrix CytoScan HD Array

ARUP Laboratories, a leading national clinical and anatomic pathology reference laboratory and a leader in innovative laboratory research and development, is pleased to introduce its newest SNP-based microarray technology, the Affymetrix CytoScan HD Array.

23 Aug 2011

AstraZeneca announces availability of BRILINTA tablets in the U.S. pharmacies

AstraZeneca today announced that BRILINTA tablets, a new oral antiplatelet therapy, is now available in pharmacies in the United States.

23 Aug 2011

QHR second quarter revenue increases 3% to $5,230,505

QHR Technologies Inc. a leader in the Canadian Healthcare Information Technology sector, is pleased to announce today the release of its second quarter financial statements for June 30, 2011 and continuing progress in its growth targets.

23 Aug 2011

FDA clears NEC's MultiSync MD215MG medical diagnostic monitor

NEC Display Solutions of America, a leading provider of commercial LCD display and projector solutions, announced today the Food & Drug Administration 510(k) market clearance of the 21.3-inch MultiSync MD215MG medical diagnostic display for the displaying and viewing of digital mammography images for diagnosis by trained physicians.

23 Aug 2011

CHL completes $18.4-million Series B financing round

Cleveland HeartLab Inc. (CHL), a leading specialty clinical laboratory and disease management company, today announced the completion of an $18.4-million Series B financing round.

23 Aug 2011

Vertex receives Health Canada approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated today announced that Health Canada has approved INCIVEK tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease, including cirrhosis.

23 Aug 2011